Trial Profile
PSN 821 +/- metformin in obese/overweight patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2011
Price :
$35
*
At a glance
- Drugs PSN 821 (Primary) ; Metformin
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Pharmacodynamics
- 03 Jul 2011 New trial record
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.